Pyrrolo [2,3-D] pyrimidine compounds for treating transplant rejection

Details for Australian Patent Application No. 2004305317 (hide)

Owner Pfizer Products Inc.

Inventors Changelian, Paul Steven

Agent Allens Arthur Robinson

Pub. Number AU-A-2004305317

PCT Pub. Number WO2005/060972

Priority 60/531,180 17.12.03 US

Filing date 6 December 2004

Wipo publication date 7 July 2005

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/060972 Priority application(s): WO2005/060972

25 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004305318-Methods of treating acute inflammation in animals with p38 MAP kinase inhibitors

2004305312-Microwave induced pyrolysis reactor and method